Israel bids for British AstraZeneca vaccine after trials

Israel’s homemade Brillife, having completed its first phase of covid-19 clinical trials with no side effects, has prepared 15 million shots for summer. Millions more are in negotiation from Pfizer and Moderna and latterly, AstraZeneca.

Another 417 new coronavirus infection cases were recorded on Friday and the death toll stood at 2,744. Out of 8,480 active cases, 318 were in serious condition, including 123 on ventilators. The proportion coming out positive from 55,003 tests dropped to 1.4pc


Print Friendly, PDF & Email